Progress in the design and development of phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of chronic diseases.

Stephen Shuttleworth, Franck Silva, Cyrille Tomassi, Alexander Cecil, Thomas Hill, Helen Rogers, Paul Townsend

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)81-131
    Number of pages50
    JournalProgress in medicinal chemistry
    Publication statusPublished - 2009

    Cite this